Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $130.7 million.

  • PROCEPT BioRobotics' Total Non-Current Liabilities fell 132.58% to $130.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.7 million, marking a year-over-year decrease of 132.58%. This contributed to the annual value of $131.5 million for FY2024, which is 650.07% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Total Non-Current Liabilities stood at $130.7 million, which was down 132.58% from $127.0 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Total Non-Current Liabilities registered a high of $132.4 million during Q3 2024, and its lowest value of $66.6 million during Q1 2022.
  • Over the past 5 years, PROCEPT BioRobotics' median Total Non-Current Liabilities value was $118.3 million (recorded in 2024), while the average stood at $108.4 million.
  • In the last 5 years, PROCEPT BioRobotics' Total Non-Current Liabilities skyrocketed by 6438.34% in 2023 and then plummeted by 132.58% in 2025.
  • PROCEPT BioRobotics' Total Non-Current Liabilities (Quarter) stood at $68.4 million in 2021, then soared by 61.43% to $110.5 million in 2022, then increased by 11.74% to $123.4 million in 2023, then grew by 6.5% to $131.5 million in 2024, then dropped by 0.6% to $130.7 million in 2025.
  • Its last three reported values are $130.7 million in Q3 2025, $127.0 million for Q2 2025, and $129.9 million during Q1 2025.